Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 24, 2001

View Archived Issues

Biora receives European Commission research grant for new matrix protein-based products

ConjuChem highlights fiscal 2001 progress

Thioureas as potent anti-HCMV agents with good pharmacokinetics in animals

Oral antifungal agent PLD-118 shows promise for yeast infections

Eisai to seek FDA approval for Aricept for vascular dementia

Omalizumab controls symptoms of seasonal allergic rhinitis

Graffinity and Structural GenomiX collaborate on new strategy for lead discovery

Vical obtains exclusive license to CytRx's poloxamer technology

Sanofi-Synthelabo and Cephalon collaborate to develop and market angiogenesis inhibitors

Wyeth-Ayerst and Neose Technologies enter R&D licensing agreement

Sulfonamidopyrimidines from Actelion act as endothelin antagonists

BMS patents new series of IMPDH inhibitors

Protein kinase modulators and use in cancer described by Sugen

Somatostatin analogues useful in the treatment of cancer designed by Indian group

Ultra-short-acting hypnotics under study at Aryx

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...